Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT05319028 · TERMINATED
Trial details
- NCT number
- NCT05319028
- Sponsor
- Calithera Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2023-02-24
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.